Preparation method of Pralatrexate suitable for industrial large scale production

A synthetic method and industrial technology, applied in the field of preparation and purification of the antineoplastic drug pralatrexate raw material and its important intermediates, can solve the problems of difficult reaction and post-processing, low yield and purity, etc., and achieve the goal of reaction Post-processing is simple and feasible, with high purity and the effect of reducing side reactions

Active Publication Date: 2014-04-23
SINOPHARM A THINK PHARMA
View PDF4 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] There are many problems in the existing synthesis technology: For example, when synthesizing intermediate C, a mixture of monopropargyl and dipropargyl (impurity) is produced, that is, it contains three Intermediate C ("J. Med. Chem. 1993,36, 2228-2231" Joseph I. De

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of Pralatrexate suitable for industrial large scale production
  • Preparation method of Pralatrexate suitable for industrial large scale production
  • Preparation method of Pralatrexate suitable for industrial large scale production

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0035] The present invention will be further described below by specific examples.

[0036] Step 1 Synthesis of intermediate 4-methyl formate methyl phenylacetate (B)

[0037] Add 80.0g of p-carboxyphenylacetic acid to a 2 L reactor, stir to dissolve with 800 mL of anhydrous methanol, add 8.0g of p-toluenesulfonic acid, stir and heat to reflux for 24 hours, spin off the methanol under reduced pressure, and add 240 mL of water to the residue , Extract with ethyl acetate (240mL×3), combine the organic phases, wash the organic phase with 3% NaOH solution (80mL×2), and then dry with anhydrous sodium sulfate. The solvent was recovered under reduced pressure and cooled to obtain compound B as a white solid. Weight: 84.1g, yield: 91.1%, HPLC content: 97.8%.

[0038] The proton nuclear magnetic spectrum data is as follows:

[0039] 1 H NMR (300 MHz, CDCl 3 )Δ 7.91(d, J = 6.3 Hz, 2H), 7.42(d, J = 6.3 Hz, 2H), 3.84(s, 3H), 3.79(s, 2H), 3.62(s, 3H).

[0040] Step 2 Synthesis of intermediate...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of pharmaceutical chemistry technology, and more specifically relates to an anticarcinogen 10-Propargyl-10-deazaaminopterin (Pralatrexate) and synthesis of an intermediate thereof. The invention has the advantages of simple operation, low contents of related impurities, easiness in purification of intermediate, thereby avoiding purification mode of column chromatography, and the invention can be applied to large scale production of Pralatrexate bulk drug as well as preparation and purification method of important intermediates.

Description

technical field [0001] The invention belongs to the technical field of medicinal chemistry, and in particular relates to a preparation process and a purification method of an antineoplastic drug pralatrexate raw material and an important intermediate thereof. Background technique [0002] Pralatrexate, trade name Folotyn, is the first new targeted folic acid preparation approved by the FDA for the treatment of peripheral T-cell lymphoma. The chemical name of pralatrexate is 10-propargyl-10-desazaaminopterin. First disclosed in "Synthesis and Antitumor Activity of 10-Propargyl-10-deazaaminopterin" J. Medical Chem.36:2228-2231 (1993) by Joseph I. DeGraw; J William T. Colwell et al. Then Sirotanak et al. and O’Connor et al. also studied it. Its molecular structure is as follows: [0003] [0004] Pralatrexate is synthesized from p-carboxyphenylacetic acid as a starting material through a series of chemical transformations. Firstly, the intermediate 4-methyl formate, meth...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D475/08
CPCC07D475/08
Inventor 不公告发明人
Owner SINOPHARM A THINK PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap